These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 33492309)

  • 21. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
    Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
    Front Immunol; 2021; 12():697622. PubMed ID: 34777333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
    Jiménez-Cortegana C; Sánchez-Jiménez F; Pérez-Pérez A; Álvarez N; Sousa A; Cantón-Bulnes L; Vilariño-García T; Fuentes S; Martín S; Jiménez M; León-Justel A; de la Cruz-Merino L; Garnacho-Montero J; Sánchez-Margalet V
    Front Immunol; 2021; 12():801410. PubMed ID: 35154077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure.
    Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW
    Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.
    Uhel F; Azzaoui I; Grégoire M; Pangault C; Dulong J; Tadié JM; Gacouin A; Camus C; Cynober L; Fest T; Le Tulzo Y; Roussel M; Tarte K
    Am J Respir Crit Care Med; 2017 Aug; 196(3):315-327. PubMed ID: 28146645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients.
    Kiaee F; Jamaati H; Shahi H; Roofchayee ND; Varahram M; Folkerts G; Garssen J; Adcock IM; Mortaz E
    Sci Rep; 2022 Dec; 12(1):22570. PubMed ID: 36581679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination.
    Lin A; Liang F; Thompson EA; Vono M; Ols S; Lindgren G; Hassett K; Salter H; Ciaramella G; Loré K
    J Immunol; 2018 Jan; 200(1):286-294. PubMed ID: 29180488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.
    Wu H; Zhen Y; Ma Z; Li H; Yu J; Xu ZG; Wang XY; Yi H; Yang YG
    Sci Transl Med; 2016 Mar; 8(331):331ra40. PubMed ID: 27009269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin D
    Gupta A; Chander Chiang K
    Med Hypotheses; 2020 Oct; 143():110122. PubMed ID: 32759007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors.
    Jøntvedt Jørgensen M; Jenum S; Tonby K; Mortensen R; Walzl G; Du Plessis N; Dyrhol-Riise AM
    J Leukoc Biol; 2021 Jul; 110(1):177-186. PubMed ID: 33155730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoplasmic reticulum stress induced LOX-1
    Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
    Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia.
    Wang H; Tao Q; Wang Z; Zhang Q; Xiao H; Zhou M; Dong Y; Zhai Z
    J Immunol Res; 2020; 2020():7363084. PubMed ID: 33415170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid-Derived Suppressor Cells Contribute to Susceptibility to
    Onyilagha C; Kuriakose S; Ikeogu N; Jia P; Uzonna J
    J Immunol; 2018 Jul; 201(2):507-515. PubMed ID: 29898961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.
    Thompson EA; Cascino K; Ordonez AA; Zhou W; Vaghasia A; Hamacher-Brady A; Brady NR; Sun IH; Wang R; Rosenberg AZ; Delannoy M; Rothman R; Fenstermacher K; Sauer L; Shaw-Saliba K; Bloch EM; Redd AD; Tobian AAR; Horton M; Smith K; Pekosz A; D'Alessio FR; Yegnasubramanian S; Ji H; Cox AL; Powell JD
    Cell Rep; 2021 Mar; 34(11):108863. PubMed ID: 33691089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.
    Falck-Jones S; Österberg B; Smed-Sörensen A
    J Intern Med; 2023 Feb; 293(2):130-143. PubMed ID: 35996885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-derived suppressor cells in COVID-19: A review.
    Perfilyeva YV; Ostapchuk YO; Tleulieva R; Kali A; Abdolla N; Krasnoshtanov VK; Perfilyeva AV; Belyaev NN
    Clin Immunol; 2022 May; 238():109024. PubMed ID: 35489643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome.
    Bline KE; Wilt AL; Alexander RN; Andrews AN; Mertz SE; Ye F; Steele LM; Wolfe AL; Mejias A; Ramilo O
    Pediatr Res; 2024 Apr; 95(5):1288-1294. PubMed ID: 38042945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.